Your browser doesn't support javascript.
loading
Assessment of Clinical Activity of PD-1 Checkpoint Inhibitor Combination Therapies Reported in Clinical Trials.
Schmidt, Emmett V; Chisamore, Michael J; Chaney, Marya F; Maradeo, Marie E; Anderson, James; Baltus, Gretchen A; Pinheiro, Elaine M; Uebele, Victor N.
Afiliação
  • Schmidt EV; Merck and Co, Inc, Kenilworth, New Jersey.
  • Chisamore MJ; Merck and Co, Inc, Kenilworth, New Jersey.
  • Chaney MF; Merck and Co, Inc, Kenilworth, New Jersey.
  • Maradeo ME; Merck and Co, Inc, Kenilworth, New Jersey.
  • Anderson J; Merck and Co, Inc, Kenilworth, New Jersey.
  • Baltus GA; Merck and Co, Inc, Kenilworth, New Jersey.
  • Pinheiro EM; Merck and Co, Inc, Kenilworth, New Jersey.
  • Uebele VN; Merck and Co, Inc, Kenilworth, New Jersey.
JAMA Netw Open ; 3(2): e1920833, 2020 02 05.
Article em En | MEDLINE | ID: mdl-32049290
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Temas: ECOS / Aspectos_gerais Bases de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Receptor de Morte Celular Programada 1 / Imunoterapia / Neoplasias Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: JAMA Netw Open Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Temas: ECOS / Aspectos_gerais Bases de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Receptor de Morte Celular Programada 1 / Imunoterapia / Neoplasias Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: JAMA Netw Open Ano de publicação: 2020 Tipo de documento: Article